| Literature DB >> 31193752 |
Jose R Suarez-Lopez1, Myron D Gross2, Duk-Hee Lee3.
Abstract
This data article presents mean serum concentrations (wet weight and lipid standardized) of 32 persistent organic pollutants (POPs) detected in >75% of participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study across levels of POPs scores, and their corresponding coefficients of determination. POPs scores were calculated as: A) the sum of each participant's log-transformed POPs concentrations (∑ of log Pops], or B) as the sum of the participants' log-transformed concentrations of each POP divided by the groups' standard deviation of the corresponding log-transformed POP (POPs summary score. Scores were calculated for both wet weight and lipid standardized concentrations and for all 32 POPs and for PCBs and organochlorine pesticides separately. POPs summary scores analyses were used in the article "Organochlorine pesticides and polychlorinated biphenyls (PCBs) in early adulthood and blood lipids over a 23-year follow-up" [Suarez-Lopez et al., 2018].Entities:
Year: 2019 PMID: 31193752 PMCID: PMC6541699 DOI: 10.1016/j.dib.2019.103720
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Median (25th, 75th percentile) wet weight concentrations (pg/g) in serum across quartiles of 32 POP summary score. This list includes 32 POPs that were detectable in ≥75% of participants at year 2 of follow-up. Non-detectable values were replaced with 50% of the limit of detectability.
| All | Quartiles of 32 POP summary score | P-trend | R2 | ||||
|---|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||||
| Hexachlorobenzene | 154.1 (116.6–198.9) | 112.3 (95, 151.6) | 151.2 (115.9, 202.9) | 161.1 (136.8, 203.7) | 185.1 (149.4, 224.6) | <0.001 | 0.13 |
| Mirex | 24.0 (13.1–44.2) | 13.2 (6.6, 21.9) | 20.4 (7.2, 31) | 29.8 (15.8, 49.7) | 35.5 (22.8, 99.6) | <0.001 | 0.09 |
| Oxychlordane | 158.1 (116.4–209.7) | 103.7 (82, 131.2) | 135.8 (116.3, 164.6) | 181.9 (152.5, 208.2) | 237.6 (192.5, 337.1) | <0.001 | 0.56 |
| p,p’-DDE | 3478 (2357–5586) | 1682 (1134, 2636) | 3834 (2832, 5134) | 3520 (2802, 5260) | 6249 (3826, 9799) | <0.001 | 0.24 |
| p,p’-DDT | 132.7 (89.8–203.7) | 90.9 (76.4, 130.2) | 135.9 (96.3, 208.9) | 136.3 (88.4, 185.6) | 176.9 (124.5, 279.5) | <0.001 | 0.16 |
| Trans-nonachlor | 183.5 (127.5–263.8) | 101.7 (82.1, 137.8) | 156.8 (128.4, 197.9) | 222.7 (167, 264.3) | 316.9 (233.7, 481.8) | <0.001 | 0.47 |
| β-hexachlorocyclohexane | 69.5 (49.4–96.2) | 45.8 (30.9, 58.2) | 65.3 (50.2, 80.1) | 77.1 (57.4, 98.9) | 97.0 (75.7, 137.5) | <0.001 | 0.33 |
| Λ-hexachlorocyclohexane | 44.5 (18.1–121) | 20.6 (16.4, 67.1) | 57.1 (17.2, 160.4) | 56.3 (23.7, 88.8) | 58.8 (33.4, 208.4) | 0.118 | 0.01 |
| PCB74 | 92.4 (62–145.3) | 60.2 (44.3, 77.2) | 91.6 (69.5, 119.2) | 105.2 (68.2, 154.0) | 144.1 (114.7, 183.5) | <0.001 | 0.39 |
| PCB87 | 6.8 (3.5–10.2) | 4.2 (2.2, 6.1) | 6.7 (3.0, 8.5) | 7.0 (5.0, 8.7) | 11.5 (7.1, 15.1) | <0.001 | 0.22 |
| PCB99 | 90.9 (60.5–136.7) | 49.0 (37.8, 65.6) | 85.2 (66.4, 115.3) | 94.1 (80, 115.2) | 160.0 (134.6, 218.6) | <0.001 | 0.56 |
| PCB105 | 29.8 (20.4–45.8) | 17.6 (11.7, 27.1) | 30.6 (21.9, 40.1) | 28.6 (20.5, 42.3) | 48.5 (36.5, 60.2) | <0.001 | 0.32 |
| PCB118 | 138 (92.4–212.9) | 87.8 (58.1, 113.7) | 146 (108.6, 185.6) | 138.1 (108.7, 211.3) | 231.5 (188.2, 282.0) | <0.001 | 0.39 |
| PCB146 | 37.7 (25.2–61.1) | 19.1 (13.2, 21.3) | 33.4 (27.5, 38.2) | 48.3 (37, 56.3) | 83.5 (63.5, 109.6) | <0.001 | 0.61 |
| PCB153 | 330.9 (220.8–496.8) | 176.1 (146.3, 199.1) | 290.9 (265.8, 328.9) | 388.9 (351, 448.5) | 628.0 (539.2, 783.4) | <0.001 | 0.72 |
| PCB156 | 42.5 (27.7–60.4) | 23.1 (18.3, 27.7) | 35.6 (27.6, 43.8) | 48.6 (41.8, 59) | 74.5 (60.9, 109.9) | <0.001 | 0.62 |
| PCB157 | 10.7 (7.1–15.4) | 6.1 (4.8, 6.9) | 8.5 (7.1, 11.7) | 13.2 (10.1, 15.5) | 18.8 (14.9, 25.8) | <0.001 | 0.62 |
| PCB138-158 | 253.8 (187.6–362.7) | 135.4 (106.8, 162.5) | 224.3 (202.9, 266) | 273.3 (253.4, 334.4) | 468.9 (387.1, 592.7) | <0.001 | 0.67 |
| PCB167 | 13.5 (8.9–19.5) | 7.3 (5.9, 8.6) | 12.4 (9.4, 14) | 15.3 (13.5, 18.9) | 25.4 (19.1, 33) | <0.001 | 0.54 |
| PCB170 | 77.8 (57.2–123.8) | 41.5 (33.6, 49.4) | 66.8 (59.1, 76.4) | 96.8 (85.3, 110.5) | 153.4 (130.3, 195.7) | <0.001 | 0.75 |
| PCB177 | 19.6 (13.2–29.7) | 9.1 (7.8, 11.5) | 16.9 (15.3, 19.8) | 22.2 (19.7, 25.1) | 42.2 (32.9, 53.5) | <0.001 | 0.68 |
| PCB178 | 13.8 (9.7–22.3) | 6.7 (5.1, 8.9) | 11.6 (9.8, 12.9) | 16.3 (14.8, 21.7) | 32.7 (23.1, 42.6) | <0.001 | 0.67 |
| PCB180 | 205.1 (141.3–323.6) | 105.8 (83.4, 128.2) | 169.4 (144.5, 191.9) | 244.1 (225.4, 299.7) | 379.4 (334.1, 481) | <0.001 | 0.75 |
| PCB183 | 30.9 (21.1–44.6) | 16.5 (12.4, 18.7) | 29.1 (23.9, 31.2) | 36.3 (30.9, 40) | 62.5 (48.3, 76.2) | <0.001 | 0.72 |
| PCB187 | 74.4 (50.0–113.1) | 34.8 (29.1, 45.2) | 61.9 (52.9, 70.6) | 86.4 (76.5, 109.2) | 161.5 (115.2, 216.3) | <0.001 | 0.67 |
| PCB194 | 41.3 (27.3–65.9) | 20.4 (15.2, 25.9) | 32.8 (27.9, 45.4) | 50.6 (40.4, 64.7) | 83.4 (66.4, 104.8) | <0.001 | 0.64 |
| PCB195 | 11.5 (7.6–17.0) | 5.8 (4.1, 6.7) | 9.3 (7.9, 11.3) | 13.1 (11.7, 15.5) | 23.0 (18.0, 28.3) | <0.001 | 0.73 |
| PCB199 | 44.4 (28.6–68.2) | 23.3 (15.4, 28.6) | 32.6 (28.6, 43.1) | 50.6 (45.0, 66.7) | 82.1 (68.3, 111.2) | <0.001 | 0.60 |
| PCB196-203 | 47.5 (32.2–73.7) | 24.6 (19, 29.9) | 37.1 (33.2, 44.4) | 54.3 (49.4, 67.0) | 92.2 (75.8, 106.3) | <0.001 | 0.69 |
| PCB206 | 23.0 (16.0–36.0) | 13.0 (9.7, 17.0) | 19.0 (15.5, 23.5) | 28.0 (22.0, 36.0) | 40.5 (34.5, 56.0) | <0.001 | 0.47 |
| PCB209 | 9.1 (6.0–14.7) | 5.0 (3.8, 6.7) | 6.9 (5.8, 9.4) | 11.1 (8.4, 14.1) | 17.7 (13.6, 23.2) | <0.001 | 0.47 |
| PBB153 | 16.6 (10.9–24.2) | 10.4 (6.6, 13.3) | 12.5 (10.2, 22.4) | 20.7 (15.8, 27.3) | 21.4 (17, 28.8) | 0.028 | 0.03 |
Dioxin-like PCBs.
POPs median (25th, 75th percentile) lipid-standardized concentrations (pg/g) in serum across quartiles of 32 POP summary score (lipid standardized). This list includes 32 POPs that were detectable in ≥75% of participants at year 2 of follow-up. Non-detectable values were replaced with 50% of the limit of detectability.
| All | Quartiles of 32 POP summary score | P-trend | R2 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||||||
| Hexachlorobenzene | 30.0 (23.8, 38.7) | 26.3 (20.8, 30.4) | 30.7 (22.4, 41.4) | 31.1 (26.4, 38.1) | 33.5 (25.7, 42.3) | 0.001 | 0.06 | ||
| Mirex | 4.6 (2.3, 9.2) | 2.3 (1.4, 4.4) | 4.7 (3.0, 8.1) | 4.6 (2.5, 8.1) | 8.1 (4.4, 12.1) | 0.001 | 0.06 | ||
| Oxychlordane | 31.5 (24.5, 40.9) | 22.2 (18.7, 28.4) | 29.1 (23.7, 31.6) | 37.0 (30.5, 42.2) | 43.3 (37.5, 50.9) | <0.001 | 0.46 | ||
| p,p’-DDE | 723.3 (455.8, 1150.4) | 434.5 (240.1, 580.9) | 641.5 (462.9, 886.9) | 923.6 (555.6, 1436.7) | 955.7 (752.8, 1566.8) | <0.001 | 0.18 | ||
| p,p’-DDT | 26.1 (19.6, 38.7) | 21.1 (14.8, 28.7) | 25.9 (20.1, 38.5) | 27.0 (20.1, 45.7) | 28.1 (21.6, 50.1) | <0.001 | 0.10 | ||
| Trans-nonachlor | 36.7 (26.5, 50.6) | 22.9 (19.3, 30) | 32.2 (26.5, 39.9) | 43.3 (33.5, 49.7) | 58.6 (43.6, 72.1) | <0.001 | 0.37 | ||
| β-hexachlorocyclohexane | 13.7 (9.9, 18.4) | 9.9 (7.0, 13.7) | 11.9 (9.8, 14.9) | 14.9 (12.0, 21.3) | 18.1 (15.5, 25.9) | <0.001 | 0.26 | ||
| Λ-hexachlorocyclohexane | 8.9 (3.7, 24.4) | 5.4 (3.4, 14.1) | 9.5 (3.5, 25.7) | 10.1 (4.1, 18.2) | 10.6 (5.0, 40.6) | 0.258 | 0.01 | ||
| PCB74 | 3.1 (1.4, 4.6) | 2.8 (1.4, 4) | 2.7 (1.3, 4.9) | 3.0 (1.4, 5.5) | 3.8 (2.1, 5.3) | <0.001 | 0.11 | ||
| PCB87 | 0.8 (0.5, 1.3) | 0.6 (0.5, 1.1) | 0.9 (0.5, 1.6) | 0.9 (0.5, 1.3) | 0.8 (0.5, 1.7) | 0.003 | 0.05 | ||
| PCB99 | 1.3 (0.8, 2.0) | 0.9 (0.5, 1.4) | 1.3 (0.8, 1.9) | 1.6 (0.8, 2.0) | 1.6 (1.1, 2.7) | <0.001 | 0.16 | ||
| PCB105 | 0.6 (0.3, 1.1) | 0.3 (0.3, 0.6) | 0.6 (0.3, 0.9) | 0.7 (0.3, 1.0) | 1.2 (0.6, 1.9) | <0.001 | 0.23 | ||
| PCB118 | 6.2 (3.8, 8.6) | 4.6 (2.7, 6.3) | 5.6 (3.4, 8.1) | 6.8 (4.3, 9.0) | 8.3 (6, 11.4) | <0.001 | 0.30 | ||
| PCB146 | 67.7 (46.4, 92.2) | 38.7 (32.0, 41.6) | 57.3 (51.7, 66.5) | 76.7 (68.2, 88.7) | 118.5 (95.1, 143.1) | <0.001 | 0.79 | ||
| PCB153 | 49.5 (37.2, 72.7) | 27.9 (23.9, 37.2) | 45.2 (37.5, 49.6) | 55.9 (48.9, 63.5) | 85.6 (73.0, 111.6) | <0.001 | 0.73 | ||
| PCB156 | 2.0 (1.4, 3.1) | 1.2 (1.0, 1.5) | 1.7 (1.4, 2.2) | 2.2 (2.0, 3.2) | 3.8 (2.7, 4.3) | <0.001 | 0.59 | ||
| PCB157 | 2.9 (1.9, 4.4) | 1.5 (1.1, 1.8) | 2.3 (2.0, 2.8) | 3.2 (2.9, 4.3) | 5.5 (4.4, 7.9) | <0.001 | 0.70 | ||
| PCB138-158 | 0.6 (0.3, 1.5) | 0.3 (0.3, 0.8) | 0.9 (0.3, 1.6) | 0.7 (0.3, 1.4) | 1.5 (0.3, 2.2) | <0.001 | 0.11 | ||
| PCB167 | 8.2 (5.8, 12.1) | 4.8 (4.1, 6.4) | 6.8 (5.7, 8.4) | 9.2 (8.0, 12.1) | 14.0 (11.4, 16.6) | <0.001 | 0.58 | ||
| PCB170 | 0.4 (0.3, 0.8) | 0.3 (0.2, 0.4) | 0.4 (0.3, 0.6) | 0.6 (0.3, 0.9) | 1.0 (0.7, 1.3) | <0.001 | 0.41 | ||
| PCB177 | 1.6 (0.3, 2.8) | 0.4 (0.3, 1.2) | 1.4 (0.2, 1.8) | 2.2 (0.3, 2.6) | 3.6 (3.0, 5.1) | <0.001 | 0.52 | ||
| PCB178 | 14.7 (9.8, 21.4) | 7.5 (6.2, 8.8) | 12.6 (11.1, 15) | 18.0 (14.8, 20.9) | 29.0 (22.8, 36.4) | <0.001 | 0.72 | ||
| PCB180 | 15.8 (11.5, 23.4) | 8.7 (7.8, 10.6) | 14.0 (12.2, 15.1) | 19.8 (16.2, 23.6) | 28.6 (23.4, 34.7) | <0.001 | 0.75 | ||
| PCB183 | 3.8 (2.8, 5.7) | 2.0 (1.6, 2.4) | 3.4 (3.0, 3.8) | 4.7 (3.8, 5.6) | 7.5 (5.3, 8.7) | <0.001 | 0.71 | ||
| PCB187 | 6.1 (4.5, 8.8) | 3.5 (2.9, 4.1) | 5.5 (4.8, 6.3) | 7.0 (5.8, 8.5) | 10.7 (9.4, 13.4) | <0.001 | 0.77 | ||
| PCB194 | 4.6 (3.3, 6.9) | 2.8 (2.2, 3.4) | 4.1 (3.1, 5.4) | 5.4 (4.2, 7.0) | 7.8 (5.8, 9.9) | <0.001 | 0.4 | ||
| PCB195 | 8.4 (5.7, 12.0) | 4.4 (3.6, 5.6) | 7.5 (5.7, 9.2) | 9.3 (7.6, 13.2) | 14.5 (11.4, 19.4) | <0.001 | 0.59 | ||
| PCB199 | 9.6 (6.5, 13.4) | 5.2 (4.7, 6.3) | 8.2 (7.0, 9.6) | 11.1 (9.6, 12.8) | 14.9 (13.5, 21.0) | <0.001 | 0.67 | ||
| PCB196-203 | 2.3 (1.5, 3.3) | 1.2 (0.9, 1.5) | 1.8 (1.6, 2.3) | 2.6 (2.3, 3.3) | 3.8 (3.4, 4.9) | <0.001 | 0.72 | ||
| PCB206 | 1.8 (1.2, 2.7) | 1.1 (0.8, 1.3) | 1.5 (1.1, 2.0) | 2.1 (1.7, 3.0) | 3.0 (2.5, 4.0) | <0.001 | 0.38 | ||
| PCB209 | 0.28 (0.23, 0.32) | 0.28 (0.24, 0.33) | 0.26 (0.23, 0.32) | 0.29 (0.24, 0.32) | 0.26 (0.22, 0.31) | 0.751 | 0.00 | ||
| PBB153 | 3.1 (2.2, 4.8) | 2.2 (1.6, 3.2) | 2.7 (2.0, 3.9) | 4.1 (3, 5.8) | 3.9 (2.8, 5.5) | 0.04 | 0.02 | ||
POPs median (25th, 75th percentile) wet-weight concentrations (pg/g) in serum across quartiles of ∑ of 32 log POPs (based on wet weight concentrations). This list includes 32 POPs that were detectable in ≥75% of participants at year 2 of follow-up. Non-detectable values were replaced with 50% of the limit of detectability.
| Quartiles of ∑ of 32 log POPs (wet weight concentrations) | P-trend | R2 | ||||
|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | |||
| Hexachlorobenzene | 112.3 (95.0, 151.6) | 152.6 (119.4, 206.4) | 159.2 (134.8, 203.7) | 171.0 (149.4, 222.4) | <0.001 | 0.13 |
| Mirex | 13.2 (6.5, 21.9) | 19.4 (7.2, 31.0) | 30.1 (15.8, 44.3) | 42.5 (22.8, 100.0) | <0.001 | 0.10 |
| Oxychlordane | 103.7 (82, 131.2) | 139.4 (116.3, 164.6) | 181.9 (155.2, 208.2) | 237.6 (192.5, 337.1) | <0.001 | 0.54 |
| p,p’-DDE | 1682 (1134, 2636) | 3764 (2632, 5063) | 3538 (2902, 5611) | 6249 (4025, 9799) | <0.001 | 0.25 |
| p,p’-DDT | 90.9 (76.4, 130.2) | 128.1 (93.9, 204.8) | 142.3 (94.1, 185.6) | 176.9 (124.5, 279.6) | <0.001 | 0.16 |
| Trans-nonachlor | 101.7 (82.1, 137.8) | 156.8 (128.4, 197.9) | 220.4 (167, 256.4) | 316.9 (239.5, 481.8) | <0.001 | 0.47 |
| β-hexachlorocyclohexane | 45.79 (30.91, 58.22) | 65.3 (50.17, 80.31) | 76.89 (62.08, 98.85) | 96.99 (75.67, 137.49) | <0.001 | 0.33 |
| Λ-hexachlorocyclohexane | 20.6 (16.4, 67.1) | 40.2 (15.4, 160.3) | 57.3 (29.2, 88.8) | 65.5 (33.4, 211.6) | 0.04 | 0.02 |
| PCB74 | 60.2 (44.3, 77.2) | 91.9 (73.2, 124.5) | 105.2 (68.2, 154) | 144.1 (114.7, 183.5) | <0.001 | 0.36 |
| PCB87 | 4.2 (2.15, 6.1) | 6.5 (1.4, 8.3) | 7.3 (5.7, 9) | 11.2 (6.3, 15.1) | <0.001 | 0.22 |
| PCB99 | 49.0 (37.8, 65.6) | 85.2 (66.4, 111.8) | 95.8 (80.4, 122.9) | 160.0 (134.6, 218.6) | <0.001 | 0.54 |
| PCB105 | 17.6 (11.7, 27.1) | 28.8 (21.9, 40.9) | 31.5 (20.7, 42.3) | 48.5 (35.1, 60.2) | <0.001 | 0.3 |
| PCB118 | 87.8 (58.1, 113.7) | 143.8 (108.6, 185.6) | 144.4 (108.7, 211.3) | 231.5 (188.2, 282) | <0.001 | 0.37 |
| PCB146 | 19.1 (13.2, 21.3) | 33.4 (27.5, 38.7) | 48.3 (36.7, 55.8) | 83.5 (63.8, 109.6) | <0.001 | 0.59 |
| PCB153 | 176.1 (146.3, 199.1) | 290.9 (265.8, 329.5) | 388.9 (345.8, 461.7) | 628.0 (539.2, 783.4) | <0.001 | 0.71 |
| PCB156 | 23.1 (18.3, 27.7) | 36.2 (28.3, 46) | 48.6 (40.8, 59) | 74.5 (58.6, 109.9) | <0.001 | 0.6 |
| PCB157 | 6.1 (4.8, 6.9) | 8.5 (7.2, 11.8) | 12.0 (9.7, 15.5) | 18.8 (14.6, 25.8) | <0.001 | 0.6 |
| PCB138-158 | 135.4 (106.8, 162.5) | 227.1 (202.9, 267.5) | 273.3 (253.4, 335.8) | 468.9 (387.1, 592.7) | <0.001 | 0.66 |
| PCB167 | 7.3 (5.9, 8.6) | 12.4 (9.4, 14.4) | 15.4 (13, 18.9) | 25.4 (19.1, 33) | <0.001 | 0.52 |
| PCB170 | 41.5 (33.6, 49.4) | 67.6 (59.9, 76.8) | 96.8 (85.2, 110.5) | 153.4 (130.6, 195.7) | <0.001 | 0.74 |
| PCB177 | 9.1 (7.8, 11.5) | 16.8 (15.2, 19.8) | 22.2 (19.7, 24.7) | 42.2 (32.9, 53.5) | <0.001 | 0.67 |
| PCB178 | 6.7 (5.1, 8.9) | 11.7 (9.8, 13.5) | 16.0 (14.0, 21.5) | 32.7 (23.6, 42.6) | <0.001 | 0.66 |
| PCB180 | 105.8 (83.4, 128.2) | 171.5 (148.0, 203.3) | 244.0 (212.6, 299.7) | 379.4 (339.8, 481) | <0.001 | 0.74 |
| PCB183 | 16.5 (12.4, 18.7) | 28.5 (23.9, 30.8) | 36.3 (31.0, 41.5) | 62.5 (48.3, 76.2) | <0.001 | 0.72 |
| PCB187 | 34.8 (29.1, 45.2) | 61.9 (52.9, 74.9) | 85.4 (73.8, 108.6) | 161.5 (116.3, 216.3) | <0.001 | 0.66 |
| PCB194 | 20.4 (15.2, 25.9) | 34.1 (27.9, 46.1) | 47.9 (39.9, 61.5) | 83.4 (66.4, 104.8) | <0.001 | 0.63 |
| PCB195 | 5.8 (4.1, 6.7) | 9.5 (8.3, 11.4) | 12.9 (11.4, 15.2) | 23.0 (18.1, 28.3) | <0.001 | 0.72 |
| PCB199 | 23.3 (15.4, 28.6) | 35.8 (28.6, 44.7) | 48.7 (44.2, 65.4) | 82.1 (69.7, 111.2) | <0.001 | 0.6 |
| PCB196-203 | 24.6 (19, 29.9) | 37.1 (33.2, 47.3) | 53.5 (47.6, 62.4) | 92.2 (76.9, 106.3) | <0.001 | 0.69 |
| PCB206 | 13.0 (9.7, 17.0) | 19.5 (16.0, 24.5) | 27.0 (21.0, 34.0) | 40.5 (35.0, 56.0) | <0.001 | 0.47 |
| PCB209 | 5.0 (3.8, 6.7) | 7.2 (5.8, 9.7) | 11.0 (8.1, 13.8) | 17.8 (13.7, 23.2) | <0.001 | 0.47 |
| PBB153 | 10.4 (6.6, 13.3) | 12.8 (10.2, 22.4) | 20.7 (15.8, 27.3) | 22.4 (17, 28.8) | 0.03 | 0.03 |
POPs median (25th, 75th percentile) lipid-standardized concentrations (pg/g) in serum across quartiles of ∑ of 32 log POPs (based on lipid-standardized concentrations). This list includes 32 POPs that were detectable in ≥75% of participants at year 2 of follow-up. Non-detectable values were replaced with 50% of the limit of detectability.
| Quartiles of ∑ of 32 log POPs (lipid standardized concentrations) | P-trend | R-square | ||||
|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | |||
| Hexachlorobenzene | 26.3 (20.8, 30.4) | 30.4 (22.4, 37) | 32.4 (26.9, 43.5) | 33.2 (25.7, 42) | 0.001 | 0.06 |
| Mirex | 2.3 (1.4, 4.2) | 5.2 (3, 8.9) | 4.5 (1.8, 8) | 8.7 (4.7, 16.3) | <0.001 | 0.07 |
| Oxychlordane | 23.3 (18.7, 28.5) | 28.2 (23.7, 32.5) | 35.9 (29.3, 41.8) | 42.8 (37.5, 50.9) | <0.001 | 0.42 |
| P,p’-DDE | 405.1 (240.1, 564.6) | 662.4 (477.6, 886.9) | 959.9 (555.6, 1458.0) | 923.6 (752.8, 1566.8) | <0.001 | 0.20 |
| P,p’-DDT | 21.6 (14.8, 28.7) | 24.5 (19.6, 37.5) | 27 (20.1, 38.5) | 31.4 (22.0, 51.2) | <0.001 | 0.11 |
| Trans-nonachlor | 23.6 (19.3, 30.0) | 33.4 (25.6, 43) | 40.6 (32.5, 49.7) | 58.6 (43.6, 72.1) | <0.001 | 0.35 |
| β-hexachlorocyclohexane | 9.3 (6.6, 13.8) | 12.3 (10.4, 14.8) | 14.9 (11.2, 21.3) | 17.8 (15.1, 25.9) | <0.001 | 0.27 |
| Λ-hexachlorocyclohexane | 4.5 (3.3, 11.2) | 7.9 (3.4, 17.3) | 11.9 (4.5, 34) | 12.2 (5.9, 41.9) | 0.061 | 0.02 |
| PCB74 | 2.4 (1.4, 4) | 2.9 (1.5, 4.9) | 3.0 (1.4, 4.4) | 3.8 (1.6, 5.3) | <0.001 | 0.11 |
| PCB87 | 0.6 (0.4, 1.1) | 0.9 (0.5, 1.2) | 0.9 (0.5, 1.5) | 0.8 (0.5, 1.7) | 0.002 | 0.05 |
| PCB99 | 0.9 (0.5, 1.4) | 1.3 (0.8, 1.9) | 1.6 (0.9, 2.1) | 1.6 (1.1, 2.7) | <0.001 | 0.16 |
| PCB105 | 0.3 (0.3, 0.6) | 0.5 (0.3, 0.9) | 0.6 (0.3, 1.0) | 1.2 (0.7, 1.9) | <0.001 | 0.24 |
| PCB118 | 4.1 (2.7, 6.3) | 5.8 (3.4, 8.1) | 7.3 (4.4, 9.0) | 7.7 (5.8, 11.4) | <0.001 | 0.30 |
| PCB146 | 38.7 (32.0, 41.6) | 55.8 (51.7, 64.8) | 76.5 (68.2, 88.7) | 118.5 (92.8, 143.1) | <0.001 | 0.77 |
| PCB153 | 27.9 (23.9, 36.8) | 43.3 (38.5, 48.9) | 59.3 (50.6, 71.3) | 85.5 (72.4, 111.6) | <0.001 | 0.72 |
| PCB156 | 1.2 (1.0, 1.5) | 1.7 (1.4, 2.2) | 2.2 (1.9, 3.2) | 3.7 (2.6, 4.3) | <0.001 | 0.55 |
| PCB157 | 1.5 (1.1, 1.8) | 2.4 (2.1, 3.0) | 3.2 (2.8, 4.3) | 5.5 (4.4, 7.9) | <0.001 | 0.68 |
| PCB138-158 | 0.3 (0.3, 0.8) | 0.8 (0.3, 1.4) | 0.7 (0.3, 1.4) | 1.5 (0.3, 2.2) | <0.001 | 0.11 |
| PCB167 | 4.8 (4.1, 6.4) | 6.8 (5.7, 8.6) | 9.5 (7.9, 12.2) | 13.8 (11.3, 16.6) | <0.001 | 0.55 |
| PCB170 | 0.3 (0.2, 0.4) | 0.4 (0.3, 0.6) | 0.6 (0.3, 0.9) | 1.0 (0.7, 1.3) | <0.001 | 0.39 |
| PCB177 | 0.7 (0.3, 1.2) | 0.3 (0.2, 1.8) | 2.1 (0.4, 2.6) | 3.6 (2.8, 5.1) | <0.001 | 0.49 |
| PCB178 | 7.5 (6.2, 8.8) | 12.6 (11.0, 14.5) | 18.0 (15.1, 20.8) | 29.0 (23.1, 36.4) | <0.001 | 0.72 |
| PCB180 | 8.7 (7.8, 10.6) | 13.9 (11.9, 14.8) | 18.5 (16.1, 22.3) | 28.6 (23.4, 34.7) | <0.001 | 0.72 |
| PCB183 | 2.1 (1.6, 2.5) | 3.4 (3.0, 3.8) | 4.8 (3.8, 5.6) | 7.5 (5.7, 8.7) | <0.001 | 0.71 |
| PCB187 | 3.5 (2.9, 4.2) | 5.5 (4.8, 6.2) | 7.1 (6, 8.6) | 10.7 (9.4, 13.4) | <0.001 | 0.77 |
| PCB194 | 2.8 (2.2, 3.5) | 4.1 (3.1, 5.2) | 5.4 (4.2, 6.9) | 7.8 (6.0, 9.9) | <0.001 | 0.38 |
| PCB195 | 4.4 (3.6, 5.7) | 7.4 (5.7, 9.2) | 9.3 (7.6, 12.4) | 14.5 (11.5, 19.4) | <0.001 | 0.56 |
| PCB199 | 5.2 (4.7, 6.3) | 8.0 (6.6, 9.6) | 11.1 (9.6, 12.8) | 14.9 (13.5, 21) | <0.001 | 0.64 |
| PCB196-203 | 1.2 (0.9, 1.5) | 1.8 (1.6, 2.3) | 2.7 (2.2, 3.1) | 3.9 (3.4, 4.9) | <0.001 | 0.70 |
| PCB206 | 1.1 (0.8, 1.3) | 1.7 (1.1, 2.0) | 2.0 (1.6, 2.8) | 3.1 (2.5, 4.0) | <0.001 | 0.36 |
| PCB209 | 0.3 (0.2, 0.3) | 0.3 (0.2, 0.3) | 0.3 (0.2, 0.3) | 0.3 (0.2, 0.3) | 0.827 | 0.00 |
| PBB153 | 2.2 (1.6, 3.2) | 2.9 (2.1, 5.4) | 3.8 (2.7, 5.1) | 3.9 (2.8, 5.5) | 0.148 | 0.01 |
OCP median (25th, 75th percentile) wet weight concentrations (pg/g) in serum across quartiles of 8 OCP summary score. This list includes 8 OCPs that were detectable in ≥75% of participants at year 2 of follow-up. Non-detectable values were replaced with 50% of the limit of detectability.
| Quartiles of 8 OCP summary score | P-trend | R-square | ||||
|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | |||
| Hexachlorobenzene | 112.9 (98.7, 151.6) | 159 (125.1, 191.5) | 148.8 (120.9, 203.6) | 196.7 (154.9, 241.2) | <0.001 | 0.16 |
| Mirex | 6.8 (6.6, 20.2) | 20.7 (13.2, 31) | 30.2 (21.5, 54) | 42.9 (22.9, 76.8) | <0.001 | 0.12 |
| Oxychlordane | 110.5 (87.3, 131.2) | 152.4 (126.8, 181.9) | 172.9 (135.8, 217.8) | 234 (188.3, 338.6) | <0.001 | 0.46 |
| P,p’-DDE | 1831 (1134, 2513) | 2954 (2346, 3928) | 4025 (3021, 5561) | 7072 (4800, 9799) | <0.001 | 0.31 |
| P,p’-DDT | 89.8 (72.1, 123) | 123.3 (85.7, 155.7) | 153.5 (104.0, 218.4) | 228.0 (157.7, 319.4) | <0.001 | 0.25 |
| Trans-nonachlor | 101.7 (82.1, 151.3) | 165 (126.3, 205.1) | 205.5 (156.8, 263.3) | 335.2 (250.3, 488.0) | <0.001 | 0.43 |
| β-hexachlorocyclohexane | 44.4 (29.6, 62.4) | 58.2 (48.9, 72.1) | 79.9 (61.4, 98.9) | 107.4 (82.5, 140.4) | <0.001 | 0.42 |
| Λ-hexachlorocyclohexane | 17.9 (7.0, 40.3) | 32.0 (18.1, 99.3) | 55.7 (34.2, 102.1) | 115.2 (43.9, 395.3) | <0.001 | 0.07 |
PCB median (25th, 75th percentile) wet weight concentrations (pg/g) in serum across quartiles of 23 PCB summary score. This list includes 23 PCBs that were detectable in ≥75% of participants at year 2 of follow-up. Non-detectable values were replaced with 50% of the limit of detectability.
| Quartiles of 23 PCB summary score (wet weight concentrations) | P-trend | R-square | ||||
|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | |||
| PCB74 | 60.2 (45.4, 73.3) | 91.6 (73.2, 117.8) | 113.6 (72.0, 161.1) | 144.1 (114.7, 183.5) | <0.001 | 0.41 |
| PCB87 | 4.2 (1.9, 6.3) | 6.7 (3.9, 8.5) | 7.1 (5.0, 10.6) | 10.6 (6.3, 15.1) | <0.001 | 0.23 |
| PCB99 | 49.0 (37.8, 65.5) | 83.5 (63.8, 107.9) | 96.0 (80.4, 129.2) | 154.0 (134.3, 218.6) | <0.001 | 0.57 |
| PCB105 | 17.1 (11.7, 27.1) | 28.4 (20.3, 37.6) | 34.6 (20.8, 49.3) | 46.5 (32.8, 60.2) | <0.001 | 0.34 |
| PCB118 | 86.1 (58.1, 125.8) | 134.6 (93.5, 172.3) | 166.5 (118.8, 225.0) | 231.5 (182.9, 282.0) | <0.001 | 0.41 |
| PCB146 | 19.1 (13.2, 21.3) | 32.7 (27.5, 37.0) | 48.3 (41.2, 55.8) | 83.9 (64.0, 109.6) | <0.001 | 0.64 |
| PCB153 | 176.1 (146.3, 195.2) | 290.1 (261.1, 313.8) | 388.9 (353.1, 445.9) | 656.4 (552.1, 783.4) | <0.001 | 0.74 |
| PCB156 | 21.5 (18.3, 27) | 32.6 (28.0, 39.5) | 50.0 (45.6, 59.8) | 77.4 (65.5, 110.3) | <0.001 | 0.65 |
| PCB157 | 5.6 (4.8, 6.9) | 8.4 (7.3, 10.5) | 13.4 (10.7, 15.6) | 19.0 (15.1, 26.3) | <0.001 | 0.65 |
| PCB138-158 | 135.4 (106.8, 161.9) | 224.3 (203.9, 253.2) | 296.5 (255.5, 349.3) | 468.9 (388.1, 592.7) | <0.001 | 0.69 |
| PCB167 | 6.9 (5.5, 8.9) | 12.2 (9.4, 13.7) | 17.1 (13.5, 19.6) | 25.4 (18.5, 33.0) | <0.001 | 0.57 |
| PCB170 | 41.5 (33.6, 50.3) | 67.1 (57.7, 76.7) | 96.8 (78.2, 110.0) | 163.9 (133.5, 195.7) | <0.001 | 0.76 |
| PCB177 | 9.1 (7.8, 11.4) | 16.3 (15, 19.4) | 22.2 (19.7, 24.5) | 42.2 (32.9, 53.5) | <0.001 | 0.70 |
| PCB178 | 6.5 (4.4, 8.8) | 11.7 (10.0, 13.0) | 16.4 (14.8, 21.3) | 32.7 (25.0, 42.6) | <0.001 | 0.70 |
| PCB180 | 105.8 (83.4, 123.6) | 173.9 (143.8, 198.8) | 244.1 (224.7, 275.7) | 395.1 (347.3, 481.0) | <0.001 | 0.77 |
| PCB183 | 16.5 (12.4, 19.4) | 28.1 (23.2, 32.1) | 35.2 (29.5, 40) | 62.5 (47.8, 76.2) | <0.001 | 0.73 |
| PCB187 | 36.0 (29.1, 45.6) | 62.7 (53.9, 71.1) | 86.4 (75.6, 103.1) | 161.5 (124.3, 216.3) | <0.001 | 0.69 |
| PCB194 | 20.0 (15.2, 25.9) | 34.8 (28.2, 43.6) | 50.3 (39.9, 61.5) | 86.1 (66.7, 104.8) | <0.001 | 0.65 |
| PCB195 | 5.7 (4.0, 6.8) | 9.5 (8.4, 11.4) | 13.3 (11.5, 15.2) | 23.0 (18.1, 28.3) | <0.001 | 0.75 |
| PCB199 | 22.8 (15.4, 28.0) | 37.4 (29.8, 44.7) | 50.6 (44.2, 65.8) | 85.7 (69.8, 107.7) | <0.001 | 0.62 |
| PCB196-203 | 24.6 (19.0, 29.9) | 39.1 (34.6, 47.3) | 55.0 (47.6, 67) | 92.2 (77.2, 105.7) | <0.001 | 0.70 |
| PCB206 | 13.0 (9.7, 16.0) | 20.0 (16.0, 24.0) | 28.0 (22.0, 34.0) | 41.0 (35.0, 56.0) | <0.001 | 0.48 |
| PCB209 | 5.0 (3.8, 6.3) | 7.2 (5.9, 9.7) | 10.9 (8.1, 14.1) | 17.7 (13.6, 23.2) | <0.001 | 0.46 |
Specifications table
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility | |
| Related research article |
POPs composite scores are used in epidemiologic studies to reduce the number of associations tested, thus reducing the potential for spurious findings, and because the general population is exposed to a mixture of POPs. This article presents coefficients of determination (R2) between specific POPs and various POPs scores, thus providing further exposure information of our published work using POPs summary scores. This article provides deeper insight on POPs summary scores and their relationships with specific POPs exposure levels. These data can be used by investigators who are conducting analyses using POPs score analyses and provides information to compare exposure levels between the CARDIA study and other studies. |